Updated
Updated · ScienceDaily · Jun 30
Scientists Find 600-Million-Year-Old Sea Anemone Antiviral System That Reverses Human MAVS Logic
Updated
Updated · ScienceDaily · Jun 30

Scientists Find 600-Million-Year-Old Sea Anemone Antiviral System That Reverses Human MAVS Logic

2 articles · Updated · ScienceDaily · Jun 30

Summary

  • Researchers identified CARDIB, a sea anemone protein that resembles the human antiviral protein MAVS but suppresses immune signaling instead of activating it.
  • CRISPR tests showed CARDIB is still essential: sea anemones lacking the gene became far more vulnerable to infection, with faster viral growth and weaker antiviral responses.
  • Outdoor marine mesocosm experiments in South Carolina confirmed the pathway works in nature, where modified anemones accumulated substantially more viruses than unmodified animals within days.
  • The findings, published in Nature Ecology & Evolution, challenge the idea that animals inherited one core antiviral system and suggest evolution produced multiple distinct defenses against viruses.

Insights

Could this ancient sea anemone protein inspire new drugs for human viruses?
Why must sea anemones turn off their immune system to fight viruses?
What other immune secrets are hiding in our oceans?

Discovery of CARDIB in Sea Anemones Unveils a Counterintuitive Antiviral Strategy, Redefining Immune Evolution

Overview

A groundbreaking study published in June 2026 in Nature Ecology & Evolution revealed that sea anemones use a surprising and counterintuitive antiviral defense strategy. Researchers discovered a novel protein called CARDIB, which operates through a unique mechanism that is fundamentally different from how humans fight viruses. Instead of following the well-known human antiviral processes, CARDIB’s approach highlights that evolution can create diverse and unexpected solutions to viral threats. This finding challenges traditional views of immunity and shows that ancient organisms like sea anemones can teach us new ways to understand and potentially improve antiviral defenses.

...